To thoroughly investigate the immune-related pathway changes and the association involving expression of CMTM6 and immune signaling pathway within PAAD, GSEA enrichment assessment was performed to reveal the potential significance (adjusted P < 0.05). Here, CMTM6 is linked to pancreatic adenocarcinoma.